{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:02:45Z","timestamp":1779678165211,"version":"3.53.1"},"reference-count":28,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: This study sought to evaluate overall survival (OS) following palliative radiotherapy in glioblastoma and to identify clinically applicable predictors supporting patient-centred treatment decisions, with exploration of early mortality. Methods: This retrospective single-centre study analysed 169 glioblastoma patients treated with palliative radiotherapy between 2010 and 2025. Baseline clinical and treatment variables were assessed. OS calculated from the last day of radiotherapy was estimated using Kaplan\u2013Meier analysis; predictors were analysed using Cox regression. Early mortality (\u226430 and \u226460 days) was evaluated using logistic regression. Results: Median age at diagnosis was 75 years, median Karnofsky Performance Status (KPS) was 60%, with 63% of patients &lt; 70%. Impaired mental status, sensorimotor deficits, and steroid use were observed in 47%, 68%, and 86% of patients, respectively. Median OS was 3.5 months. Impaired mental status (HR 2.25), sensorimotor deficits (HR 1.77), steroid use (HR 1.39), multilobar involvement (HR 1.44), and age (HR 1.03) were independently associated with OS, whereas KPS was not. The rate of early mortality at 30 and 60 days was 18% and 31%. Early mortality analysis indicated impaired mental status and steroid use as indicators of very limited survival. Conclusions: Impaired mental status and steroid use identify patients with limited survival, whereas KPS lacks independent prognostic value in this setting.<\/jats:p>","DOI":"10.3390\/curroncol33060305","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:45:08Z","timestamp":1779673508000},"page":"305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Predictors of Survival After Palliative Radiotherapy for Glioblastoma in a Real-World Cohort Study"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5795-9509","authenticated-orcid":false,"given":"Felix","family":"Bock","sequence":"first","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-2692","authenticated-orcid":false,"given":"Guido","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1436-6592","authenticated-orcid":false,"given":"Bernd","family":"Frerker","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyer","family":"Roohani","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Hamburg-Eppendorf University Medical Center, 20251 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Lily","family":"F\u00e4nger","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Dzierma","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kr\u00f3likowska, K., B\u0142aszczak, K., \u0141awicki, S., Zajkowska, M., and Gudowska-Sawczuk, M. (2025). Glioblastoma\u2014A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262412162"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sipos, D., Raposa, B.L., Freihat, O., Simon, M., Mekis, N., Cornacchione, P., and Kov\u00e1cs, \u00c1. (2025). Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes. Cancers, 17.","DOI":"10.3390\/cancers17010146"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11060-025-04944-y","article-title":"Cancers of the brain and central nervous system: Global patterns and trends in incidence","volume":"172","author":"Filho","year":"2025","journal-title":"J. Neuro-Oncol."},{"key":"ref_4","first-page":"e8195","article-title":"Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Grochans, S., Cybulska, A.M., Simi\u0144ska, D., Korbecki, J., Kojder, K., Chlubek, D., and Baranowska-Bosiacka, I. (2022). Epidemiology of Glioblastoma Multiforme\u2013Literature Review. Cancers, 14.","DOI":"10.3390\/cancers14102412"},{"key":"ref_6","first-page":"46","article-title":"Palliative care in patients with glioblastoma: A systematic review","volume":"5","year":"2025","journal-title":"Med. Int."},{"key":"ref_7","first-page":"100761","article-title":"Management of glioblastoma in elderly patients: A review of the literature","volume":"46","author":"Mazarakis","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/nop\/npad070","article-title":"Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older","volume":"11","author":"Stadler","year":"2023","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11060-025-05265-w","article-title":"Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: A systematic review and meta-analysis by the Korean Society for Neuro-Oncology","volume":"176","author":"Kim","year":"2025","journal-title":"J. Neuro-Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.21873\/invivo.12282","article-title":"Palliative Radiotherapy of Primary Glioblastoma","volume":"35","author":"Witteler","year":"2021","journal-title":"Vivo"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1002\/cncr.27570","article-title":"Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older","volume":"118","author":"Scott","year":"2012","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials","volume":"85","author":"Curran","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","article-title":"Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma","volume":"81","author":"Li","year":"2011","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","article-title":"Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline","volume":"6","author":"Cabrera","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_15","first-page":"2127","article-title":"Radiotherapy for glioblastoma patients with poor performance status","volume":"148","author":"Gramatzki","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","article-title":"International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and\/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme","volume":"33","author":"Roa","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial","volume":"13","author":"Marosi","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial","volume":"22","author":"Roa","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","article-title":"Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981\/CE.3","volume":"9","author":"Gorlia","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_21","first-page":"1434","article-title":"Cognitive impairments are independently associated with shorter survival in diffuse glioma patients","volume":"268","author":"Wajer","year":"2020","journal-title":"J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/neuonc\/nos082","article-title":"Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma","volume":"14","author":"Johnson","year":"2012","journal-title":"Neuro-Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2003.10.040","article-title":"Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma","volume":"59","author":"Brown","year":"2004","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-020-03577-7","article-title":"Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients","volume":"149","author":"Butterbrod","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/nop\/npv007","article-title":"Early cognitive function tests predict early progression in glioblastoma","volume":"2","author":"Lee","year":"2015","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1200\/JCO.2025.43.16_suppl.e14022","article-title":"The significance of cognitive function assessment in treatment-na\u00efve high-grade glioma patients on clinical outcomes using neuropsychological tests: A review of current research","volume":"43","author":"Tran","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Scheffler, P., Fung, C., Momjian, S., Koessinger, D., H\u00e4ni, L., Neidert, N., Straehle, J., Volz, F., Schnell, O., and Beck, J. (2024). Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16071393"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-008-9689-z","article-title":"Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma","volume":"91","author":"Minniti","year":"2008","journal-title":"J. Neuro-Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/6\/305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:18:47Z","timestamp":1779675527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/6\/305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["curroncol33060305"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33060305","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]}}}